News Focus
News Focus
icon url

SSKILLZ1

04/30/26 12:27 PM

#130305 RE: researcher59 #130302

CNXC

The holder might not care what the business looks like they simply might want to cash out, I mean haven't they been waiting for three years is my understanding. To be honest the company should buy those shares at these prices, it is only 138 million, they should buy those shares back essentially in a three quarter pace anyway with what they normally have been doing. whether they want to buy there share from them or simply hit the open market and buy 140 million worth of shares, I expect them to eat about 10% of the share count one way or the other with the buyback at current prices over say the next 9 months. I don't think think there is anything greatly wrong with CNXC, and I do believe margins will start to really improve in the 2nd half and the next FY, having said that a seller of 6 million shares is a headwind to the stock price that is for sure. Time will tell. All is just my opinion, and I could always be wrong though.
icon url

abh3vt

04/30/26 12:53 PM

#130308 RE: researcher59 #130302

I finally found the Sched 13D/A for GBL/Sapiens:
https://capedge.com/filing/1803599/0001193125-26-031832/SCHEDULE13DA/file/1

Sapiens was listed as owning 8.8MM shares in January 2026, so they are looking to sell 68% of that amount. I think they are choosing the exact wrong time to sell based upon CNXC's own forecast, but what do I know. If both parties were smart, they'd negotiate a fair price below market and simply have the company absorb this potential overhang of shares for sale. The company did have nearly $400MM left on their repurchase authorization post Q1 which is more than enough to absorb these shares. The problem is that cash flow will be weighted toward the 2H of this year and they have stated that they are prioritizing debt reduction, so I doubt it all gets done right now. That is the problem with carrying a lot of debt, it reduces the ability to be aggressive on share repurchases.